Cambridge, MA · Founded 2019 · Privately Held (backing)
Developer of biomolecule profiling technology designed to bring new insight into biological systems and disease. Vizgen is based in Cambridge, MA and was founded in 2019. Its last reported valuation was $380 million in Apr 2022. It has raised $184 million across 6 recorded rounds; the latest was a $47.8 million early-stage round in Dec 2025.
Last reported valuation
$379.7M
Oct 2026
Priced at
—
Total raised
$184.2M
Last round
Early Stage VC
Dec 2025
Team — not yet on record
No current team members for Vizgen are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Vizgen with a free account
·Watch Vizgen: the Monday email on marks, rounds and moves
